David N Gill is Director of Evolus, Inc.. Currently has a direct ownership of 33,964 shares of EOLS, which is worth approximately $442,890. The most recent transaction as insider was on May 14, 2024, when has been sold 6,718 shares (Common Stock) at a price of $12.6 per share, resulting in proceeds of $84,646. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 34K
0% 3M change
10.29% 12M change
Total Value Held $442,890

DAVID N GILL Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 14 2024
SELL
Open market or private sale
$84,646 $12.6 p/Share
6,718 Reduced 16.51%
33,964 Common Stock
May 13 2024
SELL
Open market or private sale
$46,338 $12.72 p/Share
3,643 Reduced 8.22%
40,682 Common Stock
Feb 07 2024
BUY
Grant, award, or other acquisition
-
6,464 Added 12.73%
44,325 Common Stock
Jan 27 2023
BUY
Grant, award, or other acquisition
-
8,293 Added 17.97%
37,861 Common Stock
May 16 2022
SELL
Open market or private sale
$68,100 $13.62 p/Share
5,000 Reduced 14.46%
29,568 Common Stock
May 13 2022
SELL
Open market or private sale
$69,600 $13.1 p/Share
5,313 Reduced 13.32%
34,568 Common Stock
Jan 24 2022
BUY
Grant, award, or other acquisition
-
15,568 Added 28.08%
39,881 Common Stock
Feb 05 2021
BUY
Grant, award, or other acquisition
-
19,313 Added 44.27%
24,313 Common Stock

Also insider at

YMAB
Y-mAbs Therapeutics, Inc. Healthcare
SBBP
Strongbridge Biopharma plc
DNG

David N Gill

Director
New York, NY

Track Institutional and Insider Activities on EOLS

Follow Evolus, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EOLS shares.

Notify only if

Insider Trading

Get notified when an Evolus, Inc. insider buys or sells EOLS shares.

Notify only if

News

Receive news related to Evolus, Inc.

Track Activities on EOLS